FR2997014B1 - Composition sterile dermo-injectable - Google Patents

Composition sterile dermo-injectable

Info

Publication number
FR2997014B1
FR2997014B1 FR1260146A FR1260146A FR2997014B1 FR 2997014 B1 FR2997014 B1 FR 2997014B1 FR 1260146 A FR1260146 A FR 1260146A FR 1260146 A FR1260146 A FR 1260146A FR 2997014 B1 FR2997014 B1 FR 2997014B1
Authority
FR
France
Prior art keywords
dermo
injectable sterile
sterile composition
injectable
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1260146A
Other languages
English (en)
Other versions
FR2997014A1 (fr
Inventor
Francois Bourdon
Stephane Meunier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teoxane SA
Original Assignee
Teoxane SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47754646&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2997014(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teoxane SA filed Critical Teoxane SA
Priority to FR1260146A priority Critical patent/FR2997014B1/fr
Priority to CA2888616A priority patent/CA2888616C/fr
Priority to RS20190862A priority patent/RS59079B1/sr
Priority to BR112015009162-8A priority patent/BR112015009162B1/pt
Priority to SI201331513T priority patent/SI2912074T1/sl
Priority to RU2015118969A priority patent/RU2653729C2/ru
Priority to TR2019/11149T priority patent/TR201911149T4/tr
Priority to AU2013336274A priority patent/AU2013336274B2/en
Priority to US14/437,917 priority patent/US9907739B2/en
Priority to PL13820892T priority patent/PL2912074T5/pl
Priority to EP13820892.1A priority patent/EP2912074B2/fr
Priority to DK13820892.1T priority patent/DK2912074T4/da
Priority to ES13820892T priority patent/ES2735017T5/es
Priority to KR1020157013662A priority patent/KR102178252B1/ko
Priority to PT13820892T priority patent/PT2912074T/pt
Priority to HUE13820892 priority patent/HUE044362T2/hu
Priority to PCT/IB2013/059607 priority patent/WO2014064632A1/fr
Priority to JP2015538611A priority patent/JP6521862B2/ja
Priority to HRP20191196TT priority patent/HRP20191196T1/hr
Publication of FR2997014A1 publication Critical patent/FR2997014A1/fr
Publication of FR2997014B1 publication Critical patent/FR2997014B1/fr
Application granted granted Critical
Priority to US15/874,144 priority patent/US10307362B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR1260146A 2012-10-24 2012-10-24 Composition sterile dermo-injectable Active FR2997014B1 (fr)

Priority Applications (20)

Application Number Priority Date Filing Date Title
FR1260146A FR2997014B1 (fr) 2012-10-24 2012-10-24 Composition sterile dermo-injectable
EP13820892.1A EP2912074B2 (fr) 2012-10-24 2013-10-24 Composition stérile dermo-injectable
ES13820892T ES2735017T5 (es) 2012-10-24 2013-10-24 Composición dérmica inyectable estéril
BR112015009162-8A BR112015009162B1 (pt) 2012-10-24 2013-10-24 Gel de ácido hialurônico reticulado, processo para preparar um gel de ácido hialurônico reticulado, composições dermatológicas, kit e uso de um gel de ácido hialurônico reticulado
SI201331513T SI2912074T1 (sl) 2012-10-24 2013-10-24 Dermalni sterilni sestavek za injiciranje
RU2015118969A RU2653729C2 (ru) 2012-10-24 2013-10-24 Дермальная инъецируемая стерильная композиция
TR2019/11149T TR201911149T4 (tr) 2012-10-24 2013-10-24 Dermal enjekte edilebilir steril bileşim.
AU2013336274A AU2013336274B2 (en) 2012-10-24 2013-10-24 Dermal injectable sterile composition
US14/437,917 US9907739B2 (en) 2012-10-24 2013-10-24 Dermal injectable sterile composition
PL13820892T PL2912074T5 (pl) 2012-10-24 2013-10-24 Sterylna kompozycja do wstrzykiwania przez skórę
CA2888616A CA2888616C (fr) 2012-10-24 2013-10-24 Composition sterile dermo-injectable
DK13820892.1T DK2912074T4 (da) 2012-10-24 2013-10-24 Dermal injicerbar steril sammensætning
RS20190862A RS59079B1 (sr) 2012-10-24 2013-10-24 Dermalni injekcioni sterilni sastav
KR1020157013662A KR102178252B1 (ko) 2012-10-24 2013-10-24 피부 주사가능한 멸균 조성물
PT13820892T PT2912074T (pt) 2012-10-24 2013-10-24 Composição estéril injetável dérmica
HUE13820892 HUE044362T2 (hu) 2012-10-24 2013-10-24 Dermálisan injekciózható steril készítmény
PCT/IB2013/059607 WO2014064632A1 (fr) 2012-10-24 2013-10-24 Composition stérile dermo-injectable
JP2015538611A JP6521862B2 (ja) 2012-10-24 2013-10-24 皮膚用の注入可能な滅菌組成物
HRP20191196TT HRP20191196T1 (hr) 2012-10-24 2013-10-24 Dermalni injektivni sterilni pripravak
US15/874,144 US10307362B2 (en) 2012-10-24 2018-01-18 Dermal injectable sterile composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1260146A FR2997014B1 (fr) 2012-10-24 2012-10-24 Composition sterile dermo-injectable

Publications (2)

Publication Number Publication Date
FR2997014A1 FR2997014A1 (fr) 2014-04-25
FR2997014B1 true FR2997014B1 (fr) 2015-03-20

Family

ID=47754646

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1260146A Active FR2997014B1 (fr) 2012-10-24 2012-10-24 Composition sterile dermo-injectable

Country Status (19)

Country Link
US (2) US9907739B2 (fr)
EP (1) EP2912074B2 (fr)
JP (1) JP6521862B2 (fr)
KR (1) KR102178252B1 (fr)
AU (1) AU2013336274B2 (fr)
BR (1) BR112015009162B1 (fr)
CA (1) CA2888616C (fr)
DK (1) DK2912074T4 (fr)
ES (1) ES2735017T5 (fr)
FR (1) FR2997014B1 (fr)
HR (1) HRP20191196T1 (fr)
HU (1) HUE044362T2 (fr)
PL (1) PL2912074T5 (fr)
PT (1) PT2912074T (fr)
RS (1) RS59079B1 (fr)
RU (1) RU2653729C2 (fr)
SI (1) SI2912074T1 (fr)
TR (1) TR201911149T4 (fr)
WO (1) WO2014064632A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6906885B2 (ja) 2014-11-14 2021-07-21 ロレアル しわを減少させるためのマイクロニードルシート
FR3034195B1 (fr) * 2015-03-24 2017-04-21 Teoxane Procede d'evaluation des performances mecaniques d'un gel de comblement
DK4279537T3 (da) 2015-12-29 2026-04-20 Galderma Holding SA Kulhydrat-tværbinder
EP3895742A1 (fr) * 2016-10-13 2021-10-20 Allergan, Inc. Hydrogels d'hyaluronane coacervats pour des applications de comblement dermique
EP3562469A1 (fr) * 2016-12-29 2019-11-06 Nestlé Skin Health SA Vésicules micro- ou nanoparticulaires comprenant de l'acide hyaluronique réticulé, compositions les comprenant et leur méthode d'utilisation dans les soins de la peau
WO2018122342A1 (fr) * 2016-12-29 2018-07-05 Nestlé Skin Health Sa Vésicules multilamellaires micro- ou nanoparticulaires, compositions les comprenant et leur procédé d'utilisation dans les soins de la peau
EP3562470A1 (fr) 2016-12-29 2019-11-06 Nestlé Skin Health SA Composition comprenant un acide hyaluronique (ah) réticulé en combinaison avec un ah de faible poids moléculaire et/ou un agent stimulant la synthèse d'ah endogène
CN111727033A (zh) * 2018-02-16 2020-09-29 东洋纺株式会社 防污染剂及皮肤外用组合物
JP7374133B2 (ja) 2018-06-15 2023-11-06 クロマ－ファーマ ゲゼルシャフト エム．ベー．ハー． 安定化されたヒアルロン酸
EP3806917B1 (fr) 2018-06-15 2025-12-10 Croma-Pharma GmbH Composition d'hydrogel comprenant un polymère réticulé
WO2020005788A2 (fr) * 2018-06-29 2020-01-02 The Procter & Gamble Company Produits à deux phases
CN112165885B (zh) 2018-06-29 2023-11-07 宝洁公司 双相产品
WO2020005787A2 (fr) 2018-06-29 2020-01-02 The Procter & Gamble Company Produits à deux phases
JP7208267B2 (ja) 2018-06-29 2023-01-18 ザ プロクター アンド ギャンブル カンパニー 二相製品
CN112423798B (zh) 2018-07-06 2022-07-19 株式会社Lg化学 具有高粘弹性和高内聚性的透明质酸填充剂
BR112021000361B1 (pt) * 2018-07-10 2023-12-05 Lg Chem, Ltd Enchimentos de hidrogel de ácido hialurônico com alta capacidade de levantamento e baixa força de injeção, método para preparação dos mesmos, seringa pré enchida, biomaterial para aumentar o tecido mole e usos dos ditos enchimentos para aumentar o tecido mole e melhorar as rugas
WO2020111888A1 (fr) * 2018-11-30 2020-06-04 주식회사 엘지화학 Composition de supplément de liquide synovial comprenant de l'acide hyaluronique
CA3122116C (fr) * 2018-12-20 2023-07-18 Lg Chem, Ltd. Charge presentant d'excellentes proprietes de charge comprenant un hydrogel d'acide hyaluronique
JP1665824S (fr) 2019-08-21 2020-08-11
CN114727941A (zh) * 2019-08-30 2022-07-08 宝洁公司 包装的毛发护理组合物
EP4077402B1 (fr) 2019-12-19 2024-05-01 Croma-Pharma GmbH Hyaluronane modifié par thiol et hydrogel comprenant l'hyaluronane réticulé
WO2022094553A1 (fr) 2020-10-27 2022-05-05 The Procter & Gamble Company Conditionneur chauffant
USD1006632S1 (en) 2020-12-11 2023-12-05 The Procter & Gamble Company Container for hair care products
USD1012718S1 (en) 2020-12-21 2024-01-30 The Procter & Gamble Company Container for hair care product
US20220332902A1 (en) * 2021-04-09 2022-10-20 Colorado School Of Mines Radical crosslinked zwitterionic gels and uses thereof
WO2023082084A1 (fr) * 2021-11-10 2023-05-19 爱美客技术发展股份有限公司 Matériau sous forme de gel, son procédé de préparation, et son utilisation
CN113896915B (zh) * 2021-11-10 2024-02-13 爱美客技术发展股份有限公司 一种凝胶材料及其制备方法与应用
KR20240109279A (ko) 2021-11-29 2024-07-10 아이메이커 테크놀러지 디벨롭먼트 캄파니 리미티드 복합 겔, 제조 방법 및 응용
MX2024008654A (es) 2022-01-11 2024-09-23 Wiqo S P A Nuevos derivados de acido hialuronico como rellenos innovadores.
WO2023221082A1 (fr) * 2022-05-20 2023-11-23 爱美客技术发展股份有限公司 Matériau polymère greffé, procédé de préparation associé et son application
WO2024040480A1 (fr) * 2022-08-24 2024-02-29 爱美客技术发展股份有限公司 Matériau de gel et son procédé de préparation
CN119286070B (zh) * 2024-10-30 2026-01-13 陕西科技大学 一种基于铜离子交联改性的透明质酸水凝胶及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752843B1 (fr) * 1996-08-30 1998-10-16 Sod Conseils Rech Applic Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique
IT1303735B1 (it) 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S Acidi ialuronici reticolati e loro usi medici.
KR100375299B1 (ko) 2000-10-10 2003-03-10 주식회사 엘지생명과학 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
US20040162235A1 (en) * 2003-02-18 2004-08-19 Trubetskoy Vladimir S. Delivery of siRNA to cells using polyampholytes
US8524213B2 (en) 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
NO20044818D0 (no) 2004-11-05 2004-11-05 Bioforsk As Spermin i kosmetiske preparater
US20060105022A1 (en) 2004-11-15 2006-05-18 Shiseido Co., Ltd. Process for preparing crosslinked hyaluronic acid gel
CN101107270B (zh) 2004-11-24 2011-11-23 诺维信生物制药丹麦公司 用二乙烯基砜交联透明质酸的方法
EP1884231A1 (fr) 2006-08-01 2008-02-06 Auriga International S.A. Composition cosmétique ou pharmaceutique contenant acide hyaluronique
FR2908415B1 (fr) 2006-11-10 2009-01-23 Abr Dev Sarl Acide hyaluronique reticule et son procede de preparation
EP2366386A4 (fr) 2008-10-28 2013-11-27 Univ Santiago Compostela Systèmes nanoparticulaires élaborés à base de polymères anioniques
FR2945293B1 (fr) * 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
ES2368307B1 (es) * 2010-04-28 2012-10-17 Universidade De Santiago De Compostela Hidrogeles elaborados a base de polímeros aniónicos de origen natural.
JP2013530785A (ja) * 2010-07-12 2013-08-01 シン・プーン・ファーマシューティカル・カンパニー・リミテッド 組織増大用充填組成物

Also Published As

Publication number Publication date
HRP20191196T1 (hr) 2019-10-18
HUE044362T2 (hu) 2019-10-28
KR20150079786A (ko) 2015-07-08
AU2013336274A1 (en) 2015-05-07
CA2888616A1 (fr) 2014-05-01
JP6521862B2 (ja) 2019-05-29
KR102178252B1 (ko) 2020-11-13
RU2653729C2 (ru) 2018-05-14
US9907739B2 (en) 2018-03-06
BR112015009162B1 (pt) 2021-10-13
RS59079B1 (sr) 2019-09-30
AU2013336274B2 (en) 2017-08-24
BR112015009162A2 (pt) 2017-10-03
DK2912074T4 (da) 2022-03-14
WO2014064632A1 (fr) 2014-05-01
CA2888616C (fr) 2020-09-15
FR2997014A1 (fr) 2014-04-25
ES2735017T3 (es) 2019-12-13
PL2912074T5 (pl) 2022-04-04
TR201911149T4 (tr) 2019-08-21
EP2912074A1 (fr) 2015-09-02
US10307362B2 (en) 2019-06-04
US20150272851A1 (en) 2015-10-01
EP2912074B2 (fr) 2021-12-22
PL2912074T3 (pl) 2019-09-30
PT2912074T (pt) 2019-07-19
RU2015118969A (ru) 2016-12-20
DK2912074T3 (da) 2019-07-22
SI2912074T1 (sl) 2019-08-30
EP2912074B1 (fr) 2019-05-01
US20180140530A1 (en) 2018-05-24
ES2735017T5 (es) 2022-04-28
JP2016507592A (ja) 2016-03-10

Similar Documents

Publication Publication Date Title
LT3725778T (lt) Enzalutamido kompozicijos
DK3858405T3 (da) Sprøjte
DK3656373T3 (da) Sprøjte
BR112014032798A2 (pt) composição
EP2832391A4 (fr) Seringue
EP3275481C0 (fr) Auto-injecteur
PT2928489T (pt) Composição imunogénica
PL2825212T3 (pl) Ulepszony sposób sterylizacji
ME03413B (fr) Compositions
EP2934132A4 (fr) Désinfectant
DK2897594T3 (da) Farmaceutisk sammensætning
EP2913076A4 (fr) Seringue
EP2931176A4 (fr) Fronde médicale
EP2851085A4 (fr) Composition stérilisée
BR112014032712A2 (pt) composição
HUE049445T2 (hu) Új kompozíciók
EP2837670A4 (fr) Composition contenant un fluorobiphényle
DK2811828T3 (da) Adjuvanssammensætninger
DK2800573T3 (da) Oftalmologisk sammensætning
ES1077209Y (es) Aditamento protesico dental
EP2885023A4 (fr) Seringue
ITPO20120010A1 (it) Trasloelevatore perfezionato

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14